Rivaroxaban for the treatment of venous thromboembolism in pediatric patients-Reference-Cited by-同舟云学术

Rivaroxaban for the treatment of venous thromboembolism in pediatric patients

Published:2020-09-24 Issue:11 Volume:18 Page:733-741
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Cohen Omri¹²³^ORCID,Levy-Mendelovich Sarina¹²⁴^ORCID,Ageno Walter³^ORCID

Affiliation:

1. National Hemophilia Center, Institute of Thrombosis and Hemostasis and the Amalia Biron Research Institute, Sheba Medical Center, Tel-Hashomer, Israel

2. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Department of Medicine and Surgery, University of Insubria, Varese, Italy

4. Tisch Cancer Institue, Icahn School of Medicine, Mount Sinai Hospital, NY, USA

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2020.1823218

Reference67 articles.

1. Antithrombotic Therapy in Neonates and Children

2. Thrombosis in pediatric patients with leukemia

3. Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents – What did we learn within the last 20 years?

4. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE

5. Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of Venous Thromboembolic Complications

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study;Advances in Therapy;2023-11-21

2. Real-world experience with edoxaban for anticoagulation in children at risk for coronary artery thrombosis;Cardiology in the Young;2023-11-03

3. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data;European Journal of Clinical Pharmacology;2023-10-10

4. Determination of rivaroxaban in rat plasma by ultra‐high‐performance liquid chromatography–Q‐Orbitrap high‐resolution mass spectrometry and its application to a pharmacokinetic study;Biomedical Chromatography;2022-09-13

5. New Anticoagulants in Neonates, Children, and Adolescents;Hämostaseologie;2022-04